Opioid Crisis Hidden Truths

PRESS RELEASE: A Discussion with FDA: Explaining millions of deaths

3 min · 17 de jun de 2026
Portada del episodio PRESS RELEASE: A Discussion with FDA: Explaining millions of deaths

Descripción

In this discussion with the FDA, we explore how their disregard for science has contributed to millions of deaths. We examine the bureaucracy and laziness that has broken public and law enforcement trust, fueling the opioid crisis with fentanyl and narcotics. Current guidelines, based on outdated myths, ignore neuroscience and opioid receptor science. The DEA and CDC also played a role. We need a new solution beyond temporary fixes like Narcan, addressing the root causes. Applying pattern recognition and understanding addiction can reduce deaths, depression, and addiction. Transparency and accountability in federal actions are crucial. The FDA's failure to adapt has led to a crisis; we must bypass bureaucracy, use neuroscience, and create a better future.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Opioid Crisis Hidden Truths!

Empezar

2 meses por 1 €

Después 4,99 € / mes · Cancela cuando quieras.

  • Podcasts exclusivos
  • 20 horas de audiolibros / mes
  • Podcast gratuitos

Todos los episodios

45 episodios

Portada del episodio PRESS RELEASE: A Discussion with FDA: Explaining millions of deaths

PRESS RELEASE: A Discussion with FDA: Explaining millions of deaths

In this discussion with the FDA, we explore how their disregard for science has contributed to millions of deaths. We examine the bureaucracy and laziness that has broken public and law enforcement trust, fueling the opioid crisis with fentanyl and narcotics. Current guidelines, based on outdated myths, ignore neuroscience and opioid receptor science. The DEA and CDC also played a role. We need a new solution beyond temporary fixes like Narcan, addressing the root causes. Applying pattern recognition and understanding addiction can reduce deaths, depression, and addiction. Transparency and accountability in federal actions are crucial. The FDA's failure to adapt has led to a crisis; we must bypass bureaucracy, use neuroscience, and create a better future.

17 de jun de 20263 min
Portada del episodio Ask the Right Questions: FDA Ombudsman and the Future of the OPIOID CRISIS

Ask the Right Questions: FDA Ombudsman and the Future of the OPIOID CRISIS

The opioid crisis deeply impacts the US with rising overdose deaths fueled by fentanyl. We are tasked by the FDA with finding solutions to move past this OPIOID CRISIS!, and the FDA ombudsman plays a crucial, overlooked role. Examining opioid addiction science, brain models, and receptors can lead to solutions. Current guidelines may be insufficient, requiring bypassing bureaucracy for change. Observing near-death experiences and naloxone highlights the crisis's gravity. Rethinking our approach, with the FDA ombudsman key, combining law enforcement, neuroscience, and public health can create a future free from this crisis. Adrenaline and depression linked to addiction need a holistic approach using the latest science. FDA and CDC guidelines can form a framework for a new paradigm. The crisis's future depends on asking pertinent questions and seeking innovative solutions, with the FDA ombudsman integral.

11 de jun de 20263 min